🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Drug-coating Balloon Treatment in Coronary Artery Disease

Recruitingn/aAges 18 Years - anyAllNanjing First Hospital, Nanjing Medical University
NCT04255563 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Drug-coated balloon (DCB) is an alternative choice for patients with coronary artery disease (CAD). This study is to investigate the efficacy and safety of DCB treatment in patients with CAD.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients suitable for DCB treatment Exclusion Criteria: * Pregnancy * Contraindications to contrast media, antiplatelet therapy, or paclitaxel * Expected life less than 12 months * Cardiac shock
💊

What it tests

  • DCB treatment
📍

Where

1 site
Nanjing First Hospital
Nanjing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy